Sage Journals: Discover world-class research

Abstract

This article explores the processes that led to the inclusion of psychedelics under the 1971 Convention on Psychotropic Substances, a cornerstone of international drug control. Drawing on archival records, we analyze the narratives and dynamics that shaped this decision. Despite limited scientific evidence of public health dangers, concerns about psychedelics were amplified by sensationalized media focused on their perceived risks, including dependency potential and associations with youth counterculture. The Cold War context influenced international consensus, with Eastern Bloc nations framing drug issues as Western societal failures while Western nations emphasized drug control as a public health priority. While tobacco, alcohol, sedatives, and stimulants benefited from cultural, political, and economic advocacy, psychedelics had no such support, which facilitated their stricter regulation. However, the United States played a pivotal role in preserving allowances for psychedelic research and the use of psychedelic plants, counterbalancing proposals from France and the USSR for more restrictive measures. Building on previous studies in global drug diplomacy, the article underscores the interplay of ideological, cultural, political, and institutional factors in shaping international drug policy.

Keywords

psychedelics 1971 Convention on Psychotropic Substances UN drug conventions drug control moral panic psychedelic research

Get full access to this article

View all access options for this article.

References

Baldwin

(1999). Contagion and the State in Europe, 1830–1930 (1st ed.). Cambridge University Press. https://doi.org/10.1017/CBO9780511497544

Barrett

(2020). Child Rights and Drug Control in International Law. BRILL.

Baumeister

R. F.

Placidi

K. S.

(1983). A social history and analysis of the LSD controversy. Journal of Humanistic Psychology, 23(4), 25–58. https://doi.org/10.1177/0022167883234003

Bayer

(1989). Development of the Convention on Psychotropic Substances, 1971 [Unpublished manuscript]. https://www.tni.org/files/publication-downloads/bayer-1971convention.pdf.

Bewley-Taylor

Jelsma

(2016). UNGASS 2016: A Broken or B-r-o-a-d Consensus? (Drug Policy Briefings No. 45). Transnational Institute. https://www.tni.org/en/publication/ungass-2016-a-broken-or-b-r-o-a-d-consensus.

Bewley-Taylor

D. R.

(1999). The United States and international drug control: 1909–1997. Pinter.

Blumer

(1971). Social problems as collective behavior. Social Problems, 18(3), 298–306. https://doi.org/10.2307/799797

Boister

(2002). Human rights protections in the suppression conventions. Human Rights Law Review, 2(2), 199–227. https://doi.org/10.1093/hrlr/2.2.199

Bonson. (2018). Regulation of human research with LSD in the United States (1949–1987). Psychopharmacology, 235(2), 591–604. https://doi.org/10.1007/s00213-017-4777-4

10.

Bruhn

J. G.

De Smet

P. A.

El-Seedi

H. R.

Beck

(2002). Mescaline use for 5700 years. The Lancet, 359(9320), 1866. https://doi.org/10.1016/S0140-6736(02)08701-9

11.

Bruun

Pan

Rexed

(1975). The Gentlemen’s Club: International Control of Drugs and Alcohol. University of Chicago Press.

12.

Butlen-Ducuing

Silva

Balabanov

Thirstrup

(2025). Applying the EU regulatory framework for the clinical use of psychedelics. The Lancet Psychiatry, 12(1), 7–9. https://doi.org/10.1016/S2215-0366(24)00203-7

13.

Chatterjee

S. K.

(1979). The WHO Expert Committee on Drug Dependence. The International and Comparative Law Quarterly, 28(1), 27–51. https://doi.org/10.1093/iclqaj/28.1.27

14.

Christie

(1985). Den goda fienden: Narkotikapolitik i Norden. Rabén & Sjögren.

15.

Collins

(2021). Legalising the Drug Wars: A Regulatory History of UN Drug Control (1st ed.). Cambridge University Press. https://doi.org/10.1017/9781009058278

16.

Courtwright

D. T.

(2009). Forces of Habit: Drugs and the Making of the Modern World. Harvard University Press. https://doi.org/10.2307/j.ctvjsf4p9

17.

Csete

Kamarulzaman

Kazatchkine

Altice

Balicki

Buxton

Cepeda

Comfort

Goosby

Goulão

Hart

Kerr

Lajous

A. M.

Lewis

Martin

Mejía

Camacho

Mathieson

Obot

, …, & Beyrer

(2016). Public health and international drug policy. The Lancet, 387(10026), 1427–1480. https://doi.org/10.1016/S0140-6736(16)00619-X

18.

Dubus

(2022). Le traitement médiatique du LSD en France en 1966: De la panique morale la fin des études cliniques. Cygne Noir, 9, 36–62. https://doi.org/10.7202/1091460ar

19.

Dyck

(2005). Flashback: Psychiatric experimentation with LSD in historical perspective. The Canadian Journal of Psychiatry, 50(7), 381–388. https://doi.org/10.1177/070674370505000703

20.

Edman

(2013). An all-embracing problem description. The Swedish drug issue as a political catalyst 1982–2000. International Journal of Drug Policy, 24(6), 558–565. https://doi.org/10.1016/j.drugpo.2013.05.010

21.

Edman

(2015). Temperance and modernity: Alcohol consumption as a collective problem, 1885–1913. Journal of Social History, 49(1), 20–52. https://doi.org/10.1093/jsh/shv029

22.

Edman

(2016). Transnational nationalism and idealistic science: The alcohol question between the wars: Table 1. Social History of Medicine, 29(3), 590–610. https://doi.org/10.1093/shm/hkv138

23.

Edman

(2021). A century of dissonance and harmony in Swedish intoxication policy. In Tham

(Ed.), Retreat or entrenchment? Drug policies in the nordic countries at a crossroads (pp. 239–265). Stockholm University Press. https://doi.org/10.16993/bbo.j

24.

Edman

(2024). Den svenska berusningspolitiken: Hundra år av kunskap, okunskap och motkunskap (Första upplagan). Boréa.

25.

Fairchild

A. L.

Rosner

Colgrove

Bayer

Fried

L. P.

(2010). The EXODUS of public health what history can tell us about the future. American Journal of Public Health, 100(1), 54–63. https://doi.org/10.2105/AJPH.2009.163956

26.

Gimenez-Corte

(2010). The forms of international institutional law: An historical analysis of the scheduling decisions of narcotic drugs and psychotropic substances taken by the united nations commission on narcotic drugs. International Organizations Law Review, 7(2010), 171–221. https://ssrn.com/abstract=2375879 .

27.

Haave

Pedersen

(2021). The promise and demise of LSD psychotherapy in Norway. Social History of Medicine, 34(2), 399–416. https://doi.org/10.1093/shm/hkz128

28.

Hagerfors

A.-M.

(1970, June 7). Sverige vann hård knarkmatch. Dagens Nyheter.

29.

Hallam

Bewley-Taylor

Jelsma

(2014). Scheduling in the international drug control system (Series on Legislative Reform of Drug Policies No. 25; Transnational Institute). https://www.tni.org/en/publication/scheduling-in-the-international-drug-control-system.

30.

Ingersoll

J. E.

(1970). Report of the United States Delegation to the First Special Session of the United Nations Commission on Narcotic Drugs. Submitted to the Secretary of State. (Published in the Federal Drug Abuse and Drug Dependence Prevention, Treatment, and Rehabilitation Act of 1970. Part 3: Hearings before the Special Subcommittee on Alcoholism and Narcotics of the Committee on Labor and Public Welfare).

31.

Ingersoll

J. E.

(1971). Report of the United States Delegation to the United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Submitted to the Secretary of State. (RG 59 General Records of the Department of State 1970-73. SUBJECT-NUMERIC FILE: INCO 11-5. box: 1134. LOC: 150/66/24/2). National Archives and Records Administration.

32.

Jelsma

Walsh

(2023). Coca Chronicles: Monitoring the UN Coca Review TNI/WOLA - Issue #1: Bolivia Challenges UN Coca Leaf Ban https://www.tni.org/en/article/coca-chronicles-monitoring-the-un-coca-review.

33.

Kendall

Horning

M. F.

Berman

J. C.

(1973). The Convention on Psychotropic Substances: An analysis. Drug Abuse Council.

34.

Kiloh

L. G.

Brandon

(1962). Habituation and addiction to amphetamines. BMJ, 2(5296), 40–43. https://doi.org/10.1136/bmj.2.5296.40

35.

Kinney

Christensen

Welch

Bush

Lowenthal

(1972). A Study of International Control of Narcotics and Dangerous Drugs (No. 71–28). U.S Department of Justice.

36.

Lattin

(2010). The Harvard Psychedelic Club: how Timothy Leary, Ram Dass, Huston Smith, and Andrew Weil killed the fifties and ushered in a new age for America (1st ed.). HarperOne.

37.

League of Nations. (1936). Minutes of the twenty-first session from the Advisory Committee on Traffic in Opium and other Dangerous Drugs. May 18th— June 5th 1936 (No. C. 290. M. 176. 1936. XI).

38.

Lines

Barrett

(2018). Cannabis reform, ‘medical and scientific Purposes’ and the Vienna convention on the law of treaties. International Community Law Review, 20(5), 436–455. https://doi.org/10.1163/18719732-12341384

39.

Marks

Shachar

(2023). Drug scheduling limits access to essential medicines and should be reformed. Nature Medicine, 29(2), 294–297. https://doi.org/10.1038/s41591-022-02169-4

40.

McAllister

W. B.

(ed) (2000). Drug diplomacy in the twentieth century: An international history. Routledge.

41.

Meyer

R. E.

(1969). Adverse reactions to hallucinogenic drugs with background papers: Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, Sept. 29, 1967.

42.

Nichols

D. E.

(2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478

43.

Nougier

(2018). Taking stock: A decade of drug policy. International Drug Policy Consortium. https://idpc.net/publications/2018/10/taking-stock-a-decade-of-drug-policy-a-civil-society-shadow-report.

44.

Olson

(1969, January 16th). Sverige till attack i Genève. Dagens Nyheter.

45.

Oram

(2016). Prohibited or regulated? LSD psychotherapy and the United States food and drug administration. History of Psychiatry, 27(3), 290–306. https://doi.org/10.1177/0957154X16648822

46.

Porter

(1999). Health, civilization, and the state: A history of public health from ancient to modern times. Routledge.

47.

Rasmussen

(2008). America’s first amphetamine epidemic 1929–1971: A quantitative and qualitative retrospective with implications for the present. American Journal of Public Health, 98(6), 974–985. https://doi.org/10.2105/AJPH.2007.110593

48.

Rochefort

D. A.

Cobb

R. W.

(eds) (1994). The politics of problem definition: Shaping the policy agenda. University Press of Kansas.

49.

Room

(2012). Reform by subtraction: The path of denunciation of international drug treaties and reaccession with reservations. International Journal of Drug Policy, 23(5), 401–406. https://doi.org/10.1016/j.drugpo.2012.04.001

50.

Rosen

(1974). From medical police to social medicine: Essays on the history of health care (First edition). Science History Publications.

51.

Sanchez Petrement

(2023). Historicizing psychedelics: counterculture, renaissance, and the neoliberal matrix. Frontiers in Sociology, 8, 1–13. https://doi.org/10.3389/fsoc.2023.1114523

52.

Segal

(1974). Research in the service of mental health: Summary report of the Research Task Force of the National Institute of Mental Health. National Institute of Mental Health.

53.

Shafer

(1972). Drug use in America: Problem in perspective. The Technical Papers of the Second Report of the National Commission on Marihuana and Drug Abuse. VOLUME III: The Legal System and Drug Control. United States. National Commission on Marihuana and Drug Abuse.

54.

Smart

R. G.

Bateman

(1967). Unfavourable reactions to LSD: A review and analysis of the available case reports. Canadian Medical Association Journal, 97(20), 1214–1221.

55.

Solomon

S. G.

Murard

Zylberman

(eds) (2013). Shifting boundaries of public health: Europe in the twentieth century. University of Rochester Press.

56.

Spector

Kituses

J. L.

(1977). Constructing Social Problems. Cummings.

57.

Takács

(2024). Cops Demand Access to Psychedelic Assisted Treatment at the United Nations. https://drogriporter.hu/en/leap-psychedelics-cnd2024/.

58.

Tham

Edman

(2022). To be both in the world and yet not of it. In Christensen

M. J.

Lohne

Hörnqvist

(Eds.), Nordic criminal justice in a global context (1st ed., pp. 79–94). Routledge. https://doi.org/10.4324/9781003195504-7

59.

UN. (1946). Economic and Social Council. (16 February 1946). 1946/9(I). Commission on Narcotic Drugs. E/RES/1946/9(I). https://www.unodc.org/unodc/en/Resolutions/resolution_1946-02-16_1.html.

60.

UN. (1955). Report of the tenth session. 18 April—12 May 1955 (No. E/CN.7/303/Rev.l). Commission on Narcotic Drugs.

61.

UN. (1963). Eighteenth session. Summary record of the five hundred and eighteenth meeting (Verbatim Records No. E/CN.7/SR.518). Commission on Narcotic Drugs.

62.

UN. (1964). Nineteenth session. Summary record of the five hundred and twenty-sixth meeting (Verbatim Records No. E/CN.7/SR.526). Commission on Narcotic Drugs.

63.

UN. (1965a). Questions relating to the control of substances not under international control (No. E/CN.7/480). Commission on Narcotic Drugs.

64.

UN. (1965b). Twentieth session. Summary record of the five hundred and fifty-eighth meeting (Verbatim Records No. E/CN.7/SR.558). Commission on Narcotic Drugs.

65.

UN. (1966a). Questions relating to the Control of Substances not under International Control. Report of the Committee on Substances not under International Control. Note by the Secretary-General (No. E/CN.7/AC.6/8). United Nations.

66.

UN. (1966b). Report of the twenty-first session. 5—21 January 1966 (No. E/CN.7/501). Commission on Narcotic Drugs.

67.

UN. (1966c). Twentieth session. Summary record of the five hundred and seventy-second meeting (Verbatim Records No. E/CN.7/SR.572). Commission on Narcotic Drugs.

68.

UN. (1966d). Twenty-first session. Summary record of the five hundred and eighty-third meeting (Verbatim Records No. E/CN.7/SR.583). Commission on Narcotic Drugs.

69.

UN. (1966e). Twenty-first session. Summary record of the five hundred and seventy-third meeting (Verbatim Records No. E/CN.7/SR.573). Commission on Narcotic Drugs.

70.

UN. (1966f). Twentieth session. Summary record of the five hundred and fifty-second meeting (Verbatim Records No. E/CN.7/SR.552). Commission on Narcotic Drugs.

71.

UN. (1967a). Economic and Social Council official records, 42nd session: 1464th meeting, Monday, 16 May 1967. Economic and Social Council.

72.

UN. (1967b). Final Report of the Permanent Central Narcotics Board and Drug Supervisory Body (No. E/OB/23-E/DSB/25). Permanent Central Narcotics Board and Drug Supervisory Body.

73.

UN. (1967c). Economic and Social Council. (16 May 1967). LSD and similar substances. E/RES/1197(XLII). https://digitallibrary.un.org/record/214582?v=pdf.

74.

UN. (1967d). Permanent Central Narcotics Board. 90th Session. Control of Substances Not Under International Control (No. E/OB/W.535). Permanent Central Narcotics Board.

75.

UN. (1967e). The Control of Psychotropic Substances Not Under International Control. Legal, Administrative and Other Questions. Note by the Secretary-General (No. E/CN.7/509). United Nations.

76.

UN. (1968a). First Report of the International Narcotics Control Board (No. E/INCB/1). Permanent Narcotics Control Board.

77.

UN. (1968b). Information Letter no.6 to Members of the Commission: Control over certain amphetamine substances by inclusion in the Single Convention (No. G. XVIII 3/1/5 (4-0731). Division of Narcotic Drugs.

78.

UN. (1968c). The control of psychotropic drugs not under international control (No. E/CN.7/519). Commission on Narcotic Drugs.

79.

UN. (1968d). The control of psychotropic substances not under international control: Questionnaire to governments: replies received by the Secretary-General. (No. E/CN.7/518). United Nations.

80.

UN. (1968e). Twenty-second session. Summary record of the six hundred and eight meeting (Verbatim Records No. E/CN.7/SR.608). Commission on Narcotic Drugs.

81.

UN. (1969a). Comments by Governments on the Draft Protocol on Psychotropic Substances. Note by the Secretary-General. (No. E/CN.7/525). Commission on Narcotic Drugs.

82.

UN. (1969b). Draft report on the work of the twenty-third session (No. E/CN.7/L.305/Add.13). Commission on Narcotic Drugs.

83.

UN. (1969c). Report of the twenty-third session. 13—31 January 1969 (No. E/CN.7/523/Rev.1). Commission on Narcotic Drugs.

84.

UN. (1969d). Report to the Economic and Social Council on the Work of the Board (No. E/INCB/5) International Narcotics Control Board.

85.

UN. (1969e). Twenty-third session. Summary record of the six hundred and thirty-fifth meeting (Verbatim Records No. E/CN.7/SR.635). Commission on Narcotic Drugs.

86.

UN. (1969f). Twenty-third session. Summary record of the six hundred and thirty-first meeting (Verbatim Records No. E/CN.7/SR.631). Commission on Narcotic Drugs.

87.

UN. (1970a). Economic and Social Council official records, 48th session: 1660th meeting, Monday, 24 March 1970 (No. E/SR.1660). Economic and Social Council.

88.

UN. (1970b). Economic and Social Council official records, 48th session: 1657th meeting, Monday, 23 March 1970 (No. E/SR.1657). Economic and Social Council.

89.

UN. (1970c). Economic and Social Council official records, 48th session: 1659th meeting, Tuesday, 24 March 1970 (No. E/SR.1659). Economic and Social Council.

90.

UN. (1970d). Report of the first Special Session. Official Records: Forty-Eighth Session. (No. E/CN.7/528). Commission on Narcotic Drugs.

91.

UN. (1970e). Report to the Economic and Social Council on the Work of the Board (No. E/INCB/9). International Narcotics Control Board.

92.

UN. (1970f). Twenty-second session. Summary record of the six hundred and sixty-first (Verbatim Records No. E/CN.7/SR.661). Commission on Narcotic Drugs.

93.

UN. (1971a). Report to the Economic and Social Council on the Work of the Board (No. E/INCB/13). International Narcotics Control Board.

94.

UN. (1971b). United Nations Conference for the adoption of a Protocol on Psychotropic Substances. 11 January—19 February 1971. Official Records Volume I (No. E/CONF.58/7). United Nations.

95.

UN. (1971c). United Nations Conference for the adoption of a Protocol on Psychotropic Substances. 11 January—19 February 1971. Official Records Volume II (No. E/CONF.58/7/Add.l). United Nations.

96.

UN. (1971d). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Draft Report of the Technical Committee on Article 1 (Use of terms) (No. E/CONF.58/C.3/L.10). Commission on Narcotic Drugs.

97.

UN. (1971e). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Draft Report of the Technical Committee on Schedules I, II, III and IV. (No. E /CONF.58/C.3/L.10/Add.1). Commission on Narcotic Drugs.

98.

UN. (1971f). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Mexico: Proposal for additional article (No. E/CONF.58.L.28). Commission on Narcotic Drugs.

99.

UN. (1971g). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Report of the Technical Committee on Schedules I, II, III and IV. (No. E/CONF.58/L.47). Commission on Narcotic Drugs.

100.

UN. (1971h). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Technical Committee. Amendments to Article 1. (No. E/CONF.58/C.3/L.6). Commission on Narcotic Drugs.

101.

UN. (1971i). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Technical Committee. Amendments to Article 1. (No. E/CONF.58/C.3/L.7). Commission on Narcotic Drugs.

102.

UN. (1971j). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Technical Committee. Amendments to Article 1. (No. E/CONF.58/C.3/L.2). Commission on Narcotic Drugs.

103.

UN. (1971k). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Provisional Summary Record of the Third Plenary Meeting (Verbatim Records No. E/CONF.58/SR.3).

104.

UN. (1971l). United Nations Conference for the Adoption of a Protocol on Psychotropic Substances. Provisional Summary Record of the Twenty-Fifth Plenary Meeting (Verbatim Records No. E/CONF.58/SR.25).

105.

UN. (1976). Commentary on the Convention on Psychotropic Substances (No. E/CN.7/589). United Nations.

106.

UN. (2002). Multilateral treaties deposited with the secretary-general status as at 31 December 2002. Volume I, Part I, Chapters I to XI. United Nations. https://treaties.un.org/doc/source/publications/MTDSG/2002-vol.1-english.pdf.

107.

UN. (2008). “Making drug control ‘fit for purpose’: Building on the UNGASS decade”** Report by the Executive Director of the United Nations Office on Drugs and Crime as a contribution to the review of the twentieth special session of the General Assembly (No. E/CN.7/2008/CRP.17). https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_51/1_CRPs/E-CN7-2008-CRP17_E.pdf.

108.

UN. (2023). World Drug Report. Contemporary Issues on Drugs. (No. E.23.XI.7). United Nations Office on Drugs and Crime. https://www.unodc.org/res/WDR-2023/WDR23_Booklet_2.pdf.

109.

UN. (2024). Proposed organization of Work. 67th Session of the Commission on Narcotic Drugs 2024. United Nations Office on Drugs and Crime. https://www.unodc.org/documents/commissions/CND_CCPCJ_joint/Side_Events/202 4/2403505E_Programme_CND-eBook.final_8.03.2024.pdf.

110.

U.S. House of Representatives, Committee on Interstate and Foreign Commerce, Subcommittee on Health and the Environment. (1976). Psychotropic Substances Act: Hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-Fourth Congress, Second Session, on H.R. 5359, H.R. 685, and H.R. 1530, bills to amend the Comprehensive Drug Abuse Prevention and Control Act of 1970 and other laws to discharge obligations under the Convention on Psychotropic Substances (May 20, 1976). U.S. Government Printing Office.

111.

Wark

Galliher

J. F.

(2010). Timothy leary, richard alpert (Ram dass) and the changing definition of psilocybin. International Journal of Drug Policy, 21(3), 234–239. https://doi.org/10.1016/j.drugpo.2009.08.004

112.

WHO. (1959). Peyotl. Bulletin on Narcotics. Vol. XI, (No. 2).

113.

WHO. (1964). World Health Organization. Expert Committee on Addiction-Producing Drugs: Thirteenth report (No. 273). World Health Organization.

114.

WHO. (1965a). Eighteenth World Health Assembly, Geneva, 4-21 May 1965: Part II: plenary meetings: Verbatim records: Committees: Minutes and reports (No. 144). World Health Organization.

115.

WHO. (1965b). Official Records of the World Health Organization. Eighteenth World Health Assembly. Geneva, 4-21 May 1965. Part I. Resolutions and Decisions. Annexes (No. 143).

116.

WHO. (1967a). An analysis of the problems presented in the use of LSD. Bulletin on Narcotics, Vol. XIX (No. 1).

117.

WHO. (1967b). Control measures for certain dependence-producing drugs—Report by the Director-General (No. А20/Р & В/3). TWENTIETH WORLD HEALTH ASSEMBLY. https://iris.who.int/bitstream/handle/10665/137594/WHA20_PB-3_eng.pdf?sequence=1&isAllowed=y.

118.

WHO. (1970). World Health Organization. Expert Committee on Drug Dependence: Eighteenth report (No. 460). World Health Organization.

119.

WHO. (2025a). Annex 1. Summary assessments and recommendations of the 48th WHO ECDD, 20–22 October 2025.

120.

WHO. (2025b). Critical Review Report: Coca leaf. Agenda item 3.1.1, Expert Committee on Drug Dependence, Forty-eighth Meeting, Geneva, 20-22 October 2025.

121.

Winter

Edman

(2023). The public as infrastructure in policy processes: The case of the abolition of the Swedish alcohol rationing system. International Journal of Drug Policy, 120, 104162. https://doi.org/10.1016/j.drugpo.2023.104162

Fear and Loathing in the United Nations: The Establishment of International Control of Psychedelics Through the 1971 Convention on Psychotropic Substances

Abstract

Keywords

Get full access to this article

References